← back to search

Charlotte Billiet

University of Antwerp · BE
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, and Management of metastatic bone disease.
h-index
16
citations
1,196
works
81
NIH funding
primary concept
Medicine
email

Recent publications

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
The Lancet Oncology 2023cited by 166position: middledoi
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
International Journal of Radiation Oncology*Biology*Physics 2023cited by 37position: middledoi
The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
Journal of Thoracic Oncology 2021cited by 204position: middledoi
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Strahlentherapie und Onkologie 2021cited by 17position: middledoi
Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Strahlentherapie und Onkologie 2021cited by 2position: middledoi
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
BMC Cancer 2020cited by 46position: middledoi
PO-0694: Lung toxicity modelling in thoracic post-operative RT for NSCLC and pleural mesothelioma
Radiotherapy and Oncology 2016cited by 0position: middledoi
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis
Radiotherapy and Oncology 2013cited by 149position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dirk De Ruysscher · Maastro Clinic3 papers (2013–2020)Stéphanie Peeters · Maastro Clinic2 papers (2013–2016)Christophe Dooms · Université Grenoble Alpes2 papers (2013–2020)Amir Abdollahi · German Cancer Research Center1 papers (2020–2020)Jan Nyman · Sahlgrenska University Hospital1 papers (2021–2021)Herbert Decaluwé · Biruni University1 papers (2013–2013)Peter Wersäll · Karolinska Institutet1 papers (2021–2021)Sara Lindberg · Karolinska University Hospital1 papers (2021–2021)Rolf Lewensohn · Karolinska Institutet1 papers (2021–2021)Esther G.C. Troost · Heidelberg University1 papers (2020–2020) · 1 papers (2021–2021) · 1 papers (2021–2021)André Haraldsson · Lund University1 papers (2021–2021)Pierre Boisselier · CEA Valduc1 papers (2020–2020)Johan Vansteenkiste · GlaxoSmithKline (United States)1 papers (2013–2013) · 1 papers (2021–2021)K. Nackaerts · KU Leuven1 papers (2016–2016) · 1 papers (2021–2021)D.S. Moeller · Aarhus University1 papers (2021–2021)Lizza Hendriks · The Radiosurgery Society1 papers (2020–2020)